Alnylam Pharmaceuticals (ALNY) Enterprise Value (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly Enterprise Value of -$3.0 billion for Q1 2026, down 193.05% year-on-year from $3.2 billion in Q1 2025, and down 3.46% on a QoQ basis from -$2.9 billion in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of Enterprise Value data on file, last reported at -$3.0 billion in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 193.05% year-over-year to -$3.0 billion; the trailing twelve-month figure through Mar 2026 stood at -$3.0 billion (down 193.05% YoY), and the FY2025 full-year result was -$2.9 billion, down 197.75% from the prior year.
- Enterprise Value for Q1 2026 stood at -$3.0 billion, down from -$2.9 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$685.1 million in Q2 2023 and bottomed at -$3.0 billion in Q1 2026.
- The 5-year median for Enterprise Value is -$2.2 billion (2022), against an average of -$2.0 billion.
- The widest annual swing landed in 2023, when Enterprise Value jumped 67.06%; it then plunged 281.69% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$896.7 million in 2022, then slumped by 170.8% to -$2.4 billion in 2023, then soared by 59.77% to -$976.8 million in 2024, then plunged by 197.75% to -$2.9 billion in 2025, then dropped by 3.46% to -$3.0 billion in 2026.
- The last three Enterprise Value figures came in at -$3.0 billion (Q1 2026), -$2.9 billion (Q4 2025), and -$2.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.01 Bn |
| Dec 31, 2025 | -2.91 Bn |
| Sep 30, 2025 | -2.72 Bn |
| Jun 30, 2025 | -2.86 Bn |
| Mar 31, 2025 | -1.03 Bn |
| Dec 31, 2024 | -976.81 Mn |
| Sep 30, 2024 | -1.11 Bn |
| Jun 30, 2024 | -2.61 Bn |
| Mar 31, 2024 | -2.36 Bn |
| Dec 31, 2023 | -2.43 Bn |
| Sep 30, 2023 | -2.40 Bn |
| Jun 30, 2023 | -685.06 Mn |
| Mar 31, 2023 | -2.04 Bn |
| Dec 31, 2022 | -896.68 Mn |
| Sep 30, 2022 | -2.24 Bn |
| Jun 30, 2022 | -2.08 Bn |
| Mar 31, 2022 | -2.21 Bn |
| Dec 31, 2021 | -2.37 Bn |
| Sep 30, 2021 | -1.17 Bn |
| Jun 30, 2021 | -798.30 Mn |
| Mar 31, 2021 | -1.65 Bn |
| Dec 31, 2020 | -1.83 Bn |
| Sep 30, 2020 | -1.78 Bn |
| Jun 30, 2020 | -1.84 Bn |
| Mar 31, 2020 | -1.30 Bn |
| Dec 31, 2019 | -1.52 Bn |
| Sep 30, 2019 | -1.72 Bn |
| Jun 30, 2019 | -1.93 Bn |
| Mar 31, 2019 | -1.24 Bn |
| Dec 31, 2018 | -1.09 Bn |
| Sep 30, 2018 | -331.61 Mn |
| Jun 30, 2018 | -373.50 Mn |
| Mar 31, 2018 | -1.57 Bn |
| Dec 31, 2017 | -1.69 Bn |
| Sep 30, 2017 | -948.29 Mn |
| Jun 30, 2017 | -923.27 Mn |
| Mar 31, 2017 | -556.92 Mn |
| Dec 31, 2016 | -619.27 Mn |
| Sep 30, 2016 | -699.52 Mn |
| Jun 30, 2016 | -843.07 Mn |
| Mar 31, 2016 | -265.21 Mn |
| Dec 31, 2015 | -232.31 Mn |
| Sep 30, 2015 | -187.78 Mn |
| Jun 30, 2015 | -215.89 Mn |
| Mar 31, 2015 | -966.98 Mn |
| Dec 31, 2014 | -602.11 Mn |
| Sep 30, 2014 | -590.65 Mn |
| Jun 30, 2014 | -605.31 Mn |
| Mar 31, 2014 | -665.49 Mn |
| Dec 31, 2013 | -245.87 Mn |
| Sep 30, 2013 | -193.78 Mn |
| Jun 30, 2013 | -209.69 Mn |
| Mar 31, 2013 | -236.01 Mn |
| Dec 31, 2012 | -122.81 Mn |
| Sep 30, 2012 | -228.34 Mn |
| Jun 30, 2012 | -48.27 Mn |
| Mar 31, 2012 | -199.10 Mn |
| Dec 31, 2011 | -146.40 Mn |
| Sep 30, 2011 | -173.02 Mn |
| Jun 30, 2011 | -217.95 Mn |
| Mar 31, 2011 | -244.64 Mn |
| Dec 31, 2010 | -233.13 Mn |
| Sep 30, 2010 | -231.37 Mn |
| Jun 30, 2010 | -259.19 Mn |
| Mar 31, 2010 | -114.95 Mn |
| Dec 31, 2009 | -281.40 Mn |
| Sep 30, 2009 | -98.09 Mn |
| Jun 30, 2009 | -147.87 Mn |